GlassScriptPhysician profile
Paulina Miklosz
NPI 1356775985
$1,415.82
in general payments reported to CMS, 2019-2025
11 companies · $218 in 2025
The $218 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $51.16 · 2022: $335 · 2023: $554 · 2024: $257 · 2025: $218.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,030.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,029.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cequr Corporation | $427.90 | 2023-2025 | Cequr Simplicity |
| Dexcom, INC. | $290.27 | 2022-2023 | Dexcom G7 Gss (161) |
| Xeris Pharmaceuticals, INC. | $272.15 | 2023-2025 | Recorlev, Gvoke Hypopen |
| Abbott Laboratories | $177.95 | 2022-2023 | Freestyle Libre 3 |
| Novo Nordisk INC | $75.14 | 2021-2023 | Ozempic |
| Bayer Healthcare Pharmaceuticals INC. | $62.33 | 2023 | |
| Ascensia Diabetes Care US INC. | $27.72 | 2024 | |
| Lilly USA, LLC | $25.76 | 2023 | Lyumjev, Baqsimi, Jardiance |
| Embecta Corp. | $23.81 | 2023 | Bd Nano 2nd Gen Pen Needle |
| Redhill Biopharma INC. | $17.94 | 2022 | |
| Medtronic, INC. | $14.85 | 2023 | Minimed 780g |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paulina Miklosz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.